
Lakshmi Sarada Channavajjala
Examiner (ID: 456, Phone: (571)272-0591 , Office: P/1611 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1615, 1611 |
| Total Applications | 1737 |
| Issued Applications | 722 |
| Pending Applications | 210 |
| Abandoned Applications | 818 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6692240
[patent_doc_number] => 20030039672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Cosmetic composition and method of treating skin'
[patent_app_type] => new
[patent_app_number] => 10/211427
[patent_app_country] => US
[patent_app_date] => 2002-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3927
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20030039672.pdf
[firstpage_image] =>[orig_patent_app_number] => 10211427
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/211427 | Cosmetic composition and method of treating skin | Aug 5, 2002 | Abandoned |
Array
(
[id] => 6696381
[patent_doc_number] => 20030108575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Stabilized oral suspension formulation'
[patent_app_type] => new
[patent_app_number] => 10/212308
[patent_app_country] => US
[patent_app_date] => 2002-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11599
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20030108575.pdf
[firstpage_image] =>[orig_patent_app_number] => 10212308
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/212308 | Stabilized oral suspension formulation | Aug 4, 2002 | Abandoned |
Array
(
[id] => 6329331
[patent_doc_number] => 20020198172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Method of treating motor neuron diseases and demyelinating diseases with citicoline'
[patent_app_type] => new
[patent_app_number] => 10/207111
[patent_app_country] => US
[patent_app_date] => 2002-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6701
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20020198172.pdf
[firstpage_image] =>[orig_patent_app_number] => 10207111
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/207111 | Method of treating motor neuron diseases and demyelinating diseases with citicoline | Jul 29, 2002 | Abandoned |
| 10/129367 | Substituted nitrobenzene derivatives as medicines and other useful uses thereof | Jul 23, 2002 | Abandoned |
| 10/030977 | Composition for cosmetic or pharmacuetical use | Jul 21, 2002 | Abandoned |
Array
(
[id] => 6850976
[patent_doc_number] => 20030143179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Use of xanthan gum as a hair fixative'
[patent_app_type] => new
[patent_app_number] => 10/198469
[patent_app_country] => US
[patent_app_date] => 2002-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6734
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143179.pdf
[firstpage_image] =>[orig_patent_app_number] => 10198469
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/198469 | Use of xanthan gum as a hair fixative | Jul 17, 2002 | Issued |
Array
(
[id] => 6817331
[patent_doc_number] => 20030068289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Skin treatment'
[patent_app_type] => new
[patent_app_number] => 10/198714
[patent_app_country] => US
[patent_app_date] => 2002-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6301
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20030068289.pdf
[firstpage_image] =>[orig_patent_app_number] => 10198714
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/198714 | Skin treatment | Jul 16, 2002 | Abandoned |
Array
(
[id] => 6721385
[patent_doc_number] => 20030055075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Programmable controlled release injectable opioid formulation'
[patent_app_type] => new
[patent_app_number] => 10/195046
[patent_app_country] => US
[patent_app_date] => 2002-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13230
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20030055075.pdf
[firstpage_image] =>[orig_patent_app_number] => 10195046
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/195046 | Programmable controlled release injectable opioid formulation | Jul 11, 2002 | Abandoned |
Array
(
[id] => 6684037
[patent_doc_number] => 20030119901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Pharmaceutical formulation containing an LTB4 antagonist'
[patent_app_type] => new
[patent_app_number] => 10/192089
[patent_app_country] => US
[patent_app_date] => 2002-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4261
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119901.pdf
[firstpage_image] =>[orig_patent_app_number] => 10192089
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/192089 | Pharmaceutical formulation containing an LTB4 antagonist | Jul 9, 2002 | Abandoned |
Array
(
[id] => 6696371
[patent_doc_number] => 20030108565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres'
[patent_app_type] => new
[patent_app_number] => 10/192086
[patent_app_country] => US
[patent_app_date] => 2002-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 16385
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20030108565.pdf
[firstpage_image] =>[orig_patent_app_number] => 10192086
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/192086 | Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres | Jul 9, 2002 | Abandoned |
| 10/191265 | Compound for the amelioration of pseudofolliculitis | Jul 7, 2002 | Abandoned |
Array
(
[id] => 6855733
[patent_doc_number] => 20030129234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Methods of making sustained release formulations of oxymorphone'
[patent_app_type] => new
[patent_app_number] => 10/190383
[patent_app_country] => US
[patent_app_date] => 2002-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9199
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129234.pdf
[firstpage_image] =>[orig_patent_app_number] => 10190383
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/190383 | Methods of making sustained release formulations of oxymorphone | Jul 2, 2002 | Abandoned |
Array
(
[id] => 6856796
[patent_doc_number] => 20030130297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Oral administration of 6-hydroxy-oxymorphone for use as an analgesic'
[patent_app_type] => new
[patent_app_number] => 10/189897
[patent_app_country] => US
[patent_app_date] => 2002-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 1034
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20030130297.pdf
[firstpage_image] =>[orig_patent_app_number] => 10189897
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/189897 | Oral administration of 6-hydroxy-oxymorphone for use as an analgesic | Jul 2, 2002 | Abandoned |
Array
(
[id] => 7297539
[patent_doc_number] => 20040214849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic'
[patent_app_type] => new
[patent_app_number] => 10/189653
[patent_app_country] => US
[patent_app_date] => 2002-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 985
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214849.pdf
[firstpage_image] =>[orig_patent_app_number] => 10189653
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/189653 | Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic | Jul 2, 2002 | Abandoned |
Array
(
[id] => 6715487
[patent_doc_number] => 20030026835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Tablets disintegrating rapidly in the oral cavity'
[patent_app_type] => new
[patent_app_number] => 10/187963
[patent_app_country] => US
[patent_app_date] => 2002-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2672
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20030026835.pdf
[firstpage_image] =>[orig_patent_app_number] => 10187963
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/187963 | Tablets disintegrating rapidly in the oral cavity | Jul 2, 2002 | Abandoned |
Array
(
[id] => 12043398
[patent_doc_number] => 09820982
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-21
[patent_title] => 'Oxymorphone controlled release formulations'
[patent_app_type] => utility
[patent_app_number] => 10/190192
[patent_app_country] => US
[patent_app_date] => 2002-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12814
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10190192
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/190192 | Oxymorphone controlled release formulations | Jul 2, 2002 | Issued |
Array
(
[id] => 6760841
[patent_doc_number] => 20030124202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Formulations and methods for reducing skin irritation'
[patent_app_type] => new
[patent_app_number] => 10/189344
[patent_app_country] => US
[patent_app_date] => 2002-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12239
[patent_no_of_claims] => 92
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20030124202.pdf
[firstpage_image] =>[orig_patent_app_number] => 10189344
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/189344 | Formulations and methods for reducing skin irritation | Jul 2, 2002 | Abandoned |
Array
(
[id] => 418581
[patent_doc_number] => 07276250
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-02
[patent_title] => 'Sustained release formulations of oxymorphone'
[patent_app_type] => utility
[patent_app_number] => 10/189932
[patent_app_country] => US
[patent_app_date] => 2002-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9110
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/276/07276250.pdf
[firstpage_image] =>[orig_patent_app_number] => 10189932
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/189932 | Sustained release formulations of oxymorphone | Jul 2, 2002 | Issued |
Array
(
[id] => 6791644
[patent_doc_number] => 20030086988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Method for manufacturing nutricious supplement food and nutricious supplement food'
[patent_app_type] => new
[patent_app_number] => 10/187524
[patent_app_country] => US
[patent_app_date] => 2002-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8669
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20030086988.pdf
[firstpage_image] =>[orig_patent_app_number] => 10187524
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/187524 | Method for manufacturing nutricious supplement food and nutricious supplement food | Jul 1, 2002 | Abandoned |
Array
(
[id] => 1275760
[patent_doc_number] => 06645513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-11-11
[patent_title] => 'Treatment of skin with adenosine or adenosine analog'
[patent_app_type] => B2
[patent_app_number] => 10/184810
[patent_app_country] => US
[patent_app_date] => 2002-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 4661
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/645/06645513.pdf
[firstpage_image] =>[orig_patent_app_number] => 10184810
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/184810 | Treatment of skin with adenosine or adenosine analog | Jun 27, 2002 | Issued |